Drug-Initiated Activity Metabolomics Identifies Myristoylglycine as a Potent Endogenous Metabolite for Human Brown Fat Differentiation is a research paper published in Metabolites (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R35 GM130385
National Institutes of Health
Grant: P30 MH062261
National Institutes of Health
Grant: P01 DA026146
National Institutes of Health
Grant: U01 CA235493
National Institutes of Health
Grant: DK114785
National Institutes of Health
Grant: S10OD16357
National Institutes of Health
Grant: LCF/BQ/PR21/11840001
NIDDK NIH HHS
Grant: RC2 DK114785
NIH HHS
Grant: S10 OD016357
NIDDK NIH HHS
Grant: R01 DK121196
National Institutes of Health
Grant: 1S10OD016357-01
Seahorse XF96 Extracellular Flux Analyzer
National Institutes of Health
Grant: 5R35GM130385-04
Metabolomics Technologies to Advance Biomedical Research
National Institutes of Health
Grant: 1RC2DK114785-01
Chemoproteomic Identification and Therapeutic Validation of Proteins of Metabolic Significance
National Institutes of Health
Grant: 1U01CA235493-01
Mummichog 3, aligning mass spectrometry data to biological networks
National Institutes of Health
Grant: 5P30MH062261-17
Chronic HIV Infection and Aging in NeuroAIDS (CHAIN) Center
National Institutes of Health
Grant: 1P01DA026146-01
Biostatistics Core
FWCI
0.33
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals